121 related articles for article (PubMed ID: 20227944)
21. Inhibition of human and rat hepatic aminotransferase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase.
Waterhouse MJ; Chia YC; Lees GJ
Mol Pharmacol; 1979 Jan; 15(1):108-14. PubMed ID: 423884
[No Abstract] [Full Text] [Related]
22. Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
Masturzo P; Murialdo G; Carolei A; Polleri A
Boll Soc Ital Biol Sper; 1979 Feb; 55(4):366-72. PubMed ID: 552852
[TBL] [Abstract][Full Text] [Related]
23. The metabolism of a tryptophan load in rat brain and liver: the influence of L-alpha-methyldopa hydrazine (MK-486, Carbidopa).
Joseph MH; Hall-Tipping DL
Biochem Soc Trans; 1978; 6(5):997-1000. PubMed ID: 744365
[No Abstract] [Full Text] [Related]
24. Large amounts of picolinic acid are lethal but small amounts increase the conversion of tryptophan-nicotinamide in rats.
Shibata K; Fukuwatari T
J Nutr Sci Vitaminol (Tokyo); 2014; 60(5):334-9. PubMed ID: 25744422
[TBL] [Abstract][Full Text] [Related]
25. The pathway of biosynthesis of nicotinamide-adenine dinucleotide in rat mammary gland.
Greenbaum AL; Pinder S
Biochem J; 1968 Mar; 107(1):55-62. PubMed ID: 4296054
[TBL] [Abstract][Full Text] [Related]
26. Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
Tayarani-Binazir KA; Jackson MJ; Strang I; Jairaj M; Rose S; Jenner P
Behav Pharmacol; 2012 Apr; 23(2):126-33. PubMed ID: 22236652
[TBL] [Abstract][Full Text] [Related]
27. Carbidopa Alters Tryptophan Metabolism in Breast Cancer and Melanoma Cells Leading to the Formation of Indole-3-Acetonitrile, a Pro-Proliferative Metabolite.
Duarte D; Amaro F; Silva I; Silva D; Fresco P; Oliveira JC; Reguengo H; Gonçalves J; Vale N
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450593
[TBL] [Abstract][Full Text] [Related]
28. The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
Juorio AV
Neuropharmacology; 1983 Jan; 22(1):71-3. PubMed ID: 6843786
[TBL] [Abstract][Full Text] [Related]
29. Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
Rappelli A; Glorioso N; Tedde R; Dessi'-Fulgheri P; Monaco F
J Neurol Neurosurg Psychiatry; 1978 Oct; 41(10):915-8. PubMed ID: 731241
[TBL] [Abstract][Full Text] [Related]
30. Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations.
Contin M; Lopane G; Passini A; Poli F; Iannello C; Guarino M
Clin Neuropharmacol; 2015; 38(5):201-3. PubMed ID: 26366963
[TBL] [Abstract][Full Text] [Related]
31. Combined use of benserazide and carbidopa in Parkinson's disease.
Lieberman AN; Goldstein M; Gopinathan G; Neophytides A; Hiesiger E; Walker R; Nelson J
Neurology; 1984 Feb; 34(2):227-9. PubMed ID: 6538015
[TBL] [Abstract][Full Text] [Related]
32. Effects of vitamin B6 deficiency on the conversion ratio of tryptophan to niacin.
Shibata K; Mushiage M; Kondo T; Hayakawa T; Tsuge H
Biosci Biotechnol Biochem; 1995 Nov; 59(11):2060-3. PubMed ID: 8541642
[TBL] [Abstract][Full Text] [Related]
33. Levodopa with benserazide or carbidopa in Parkinson disease.
Rinne UK; Mölsä P
Neurology; 1979 Dec; 29(12):1584-9. PubMed ID: 574221
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues.
Lyles GA; Callingham BA
Biochem Pharmacol; 1982 Apr; 31(7):1417-24. PubMed ID: 7092930
[TBL] [Abstract][Full Text] [Related]
35. Effect of nicotinamide intake on urinary excretion of N1-methylnicotinamide and oxidation of [7a-14C]tryptophan in the rat.
Patterson JI; Harper AE
J Nutr; 1982 Apr; 112(4):776-81. PubMed ID: 6461734
[TBL] [Abstract][Full Text] [Related]
36. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
[TBL] [Abstract][Full Text] [Related]
37. Effects of sex hormones on the metabolism of tryptophan to niacin and to serotonin in male rats.
Shibata K; Toda S
Biosci Biotechnol Biochem; 1997 Jul; 61(7):1200-2. PubMed ID: 9255986
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R
DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5-hydroxytryptamine, dopamine, and aromatic L-amino acids on growth hormone (GH)-releasing factor-stimulated GH release in rat anterior pituitaries.
Lindström P; Ohlsson L
Endocrinology; 1987 Feb; 120(2):780-4. PubMed ID: 3100280
[TBL] [Abstract][Full Text] [Related]
40. Effect of leucine on enzymes of the tryptophan-niacin metabolic pathway in rat liver and kidney.
Ghafoorunissa ; Rao BS
Biochem J; 1973 Jun; 134(2):425-30. PubMed ID: 16742801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
